Clinical trial
A Phase III Study of Docetaxel and S-1 Versus S-1 in the Treatment of Advanced Gastric Cancer
NCT00287768 is registered in ClinicalTrials.gov with Japan Clinical Cancer Research Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study of Docetaxel and S-1 Versus S-1 in the Treatment of Advanced Gastric Cancer
- Lead sponsor
- Japan Clinical Cancer Research Organization
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- October 31, 2010
- Enrollment
- 628 (estimated)
- Sites
- 116
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer